Meng, Gang
Li, Binghua
Chen, Anxian
Zheng, Meihong
Xu, Tiancheng
Zhang, Hailin
Dong, Jie
Wu, Junhua
Yu, Decai
Wei, Jiwu
Article History
Received: 27 May 2019
Revised: 20 September 2019
Accepted: 28 October 2019
First Online: 10 December 2019
Competing interests
: The authors declare no competing interests.
: All animal experiments were conducted with the approval of the Ethics Committee of the Affiliated Drum Tower Hospital of Nanjing University Medical School. Animal welfare was closely monitored in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The human HCC cell line HCCLM3 and mouse HCC cell line H22 were acquired from the China Center for Type Culture Collection (Wuhan, China), the mouse HCC cell line Hepa1-6 was acquired from Cell Bank of Type Culture Collection Chinese Academy of Sciences (Shanghai, China).
: This work was supported by the National Natural Science Foundation of China (81773255, 81700037, 81871967, and 81903147), the Natural Science Foundation of Jiangsu Province of China (BK20171098), Social Development Foundation of Jiangsu Province of China (BE2018604), Six talent peaks project in Jiangsu Province to J.W., Jiangsu Provincial Medical Talent to D.Y., and Project funded by China Postdoctoral Science Foundation (2018M642223).
: Not applicable.
: All data and materials generated during and/or analysed during the current study are available from the corresponding author on reasonable request.